Purpose: To conduct a retrospective review and quality assurance study of inferior vena cava (IVC) filter retrieval over a two-year period at a tertiary care centre. Methods: Patients who underwent IVC filter placement or retrieval over a two-year period were identified. Medical records were reviewed for patient characteristics, filter indication, time to filter retrieval, and complications. Results: IVC filters were placed in 229 patients between January 1, 2015 and December 31, 2016. 113 retrievals were attempted and 101 filters were successfully retrieved (89.4%). Median time to first retrieval attempt was 48 days (range of 5e728). Seventy-one patients died in the interval after filter insertion before a retrieval attempt at a median time of 27 days (range of 3e430). In 17 patients, retrieval was complicated by or delayed because of penetration of IVC wall (n ¼ 6), large thrombus burden trapped by filter (n ¼ 5), filter tilt or migration (n ¼ 3), and unclear reasons (n ¼ 3). Time-to-first unsuccessful retrieval attempt was 141 days (median). Of all filters placed, 55.9% were never retrieved. Excluding deceased patients with in-situ filters (n ¼ 71) and unsuccessful retrievals left in-situ as permanent filters (n ¼ 5), there remains 52 patients (33%), with a median filter in-situ time of 488 days. Conclusion: Our study indicates that as many as 33% of patients may have been lost to follow-up of their in-situ IVC filter. Considering widespread reports of long-term complications and the recent safety alert issued by Health Canada, it is evident that a unified strategy is needed to track patients post filter insertion.
Conclusion : Notre etude r ev ele que jusqu' a 33 % des patients ont et e perdus de vue a l' etape du suivi relatif a leur filtre de VCI. Au vu des nombreux cas de complications a long terme et du r ecent avis de s ecurit e publi e par Sant e Canada, il convient manifestement d'adopter une strat egie concert ee de suivi des patients ayant subi une intervention d'insertion de filtre. Ó 2018 Canadian Association of Radiologists. All rights reserved.
Key Words: IVC filter; Retrieval; Retrieval rate; Quality assurance; Deep vein thrombosis Inferior vena cava filters (IVCf) reduce the risk of pulmonary embolism (PE) in appropriately selected patients. Retrievable filters were developed with the intention of avoiding the long-term complications associated with permanent IVCf by allowing filter retrieval when anticoagulation can be safely started or restarted. However, the indications for IVCf placement have not been derived from, nor studied with, the same methodological rigor that has been applied to anticoagulation [1] . To date, there are only 2 randomized controlled trials of IVCf use. One of these, The PREPIC study evaluated the long-term use of permanent IVCf [2] . Patients with deep vein thrombosis (DVT) with or without PE were randomized to either IVCf placement with concomitant anticoagulation or sole anticoagulation therapy. Although the incidence of PE was significantly lower in the filter group, the incidence of DVTs was significantly higher in this group at 2 and 8 years [2] . In addition to filter-related DVT, other complications associated with indwelling IVCf include filter fracture with and without embolization, filter migration, IVC penetration, and thrombotic IVC occlusion, with reported cases of life-threatening complications such as intracardiac migration, cardiac perforation, and cardiac tamponade [3] .
There is a growing consensus that increased dwell time may result in increased complications. A systematic literature review of retrievable IVCf by Angel et al identified that 93% of complications occurred after 30 days of filter placement, the most common being filter fracture and migration [4] . Retrievable IVCf can theoretically circumvent the long-term complications of permanent filters with timely follow-up and removal; however, retrieval rates documented in literature remain poor and have ranged from 11%e46% [5, 6] . In light of receiving numerous adverse reports, in 2010, the United States Federal Drug Administration issued a safety communication recommending removal of retrievable filters as soon as they are no longer indicated [7] . More recently, in July 2016, Health Canada (HC) issued a safety alert after receiving 121 incident reports of complications from long-term IVCf implantation (greater than 30 days). HC encouraged each hospital to create a strategy to identify patients with IVCf who have been lost to follow-up and to schedule filter retrieval as soon as anticoagulation could be started [3] . Moreover, the 2015 Canadian clinical practice guidelines for the diagnosis and management of ileofemoral DVT developed by Liu et al further emphasized the need for timely filter retrieval and recommends IVCf placement in patients with ileofemoral DVT with a contraindication to anticoagulation and who have scheduled follow-up [8] .
Prolonged dwell time is a predictor of retrieval failure [9e 12]. Factors associated with retrieval failure include severe filter tilt, tip embedment, filter penetration into IVC wall, and caval occlusion [13] . Thus, expertise in advanced retrieval techniques are often required when standard techniques (snare device) fail. Several studies have demonstrated the high success rate of advanced retrieval techniques and relatively low complication risk [13e15]. This highlights the importance of timely follow-up of patients with IVCf and the importance of identifying patients lost to follow-up given the ability of advanced techniques to retrieve filters with prolonged dwell times.
We performed a retrospective quality assurance study to evaluate the current state of IVCf retrieval over a 2-year timespan at a Canadian tertiary care institution to gain a better understanding of local practice patterns and to identify and recall patients who may be candidates for IVCf retrieval and those that have been lost to follow-up. To our knowledge, there has only been one retrospective review on this topic in Western Canada and this dates back to 2010, well before the Health Canada Safety Alert was issued.
Methods
Institutional review board approval and a waiver of informed consent were obtained for this study. A retrospective review of all patients who underwent placement or retrieval of an IVCf at a tertiary care institution over 2 years (2015e2016 inclusive) was conducted. Picture Archiving and Communication System was searched with procedure descriptors to identify all patients who underwent placement, retrieval, or attempted and unsuccessful filter retrieval. Procedure descriptors included ''IVCf insertion,'' ''IVCf procedure,'' ''IVCf retrieval,'' ''IVCf removal,'' and ''foreign body retrieval/removal.'' Patient demographics and clinical and procedural details, including indication for filter placement, access site, type of filter, and complications, were collected in an anonymous fashion from procedure requisition forms and radiology reports. Subsequently, an integrated provincial electronic health-record resource was used to identify patients who underwent filter retrieval at an outside institution or who may have died in the interval since filter placement. When available, recent images were analyzed to confirm the presence or absence of an IVCf. In cases of incomplete information, the patient's electronic medical record, including discharge summaries, consultations, and clinic notes, were assessed for clarification. Indications for filter insertion were tabulated on the basis of the Society of Interventional Radiology Guidelines [16] . Patients who had unsuccessful retrievals and documentation stating that the filter will be left in-situ as a permanent filter were not considered lost to follow-up in our study.
IVCf Insertion and Retrieval Technique
The majority of filters (n ¼ 176, 77%) were placed via a femoral approach and the remaining 51 (23%) filters via a jugular approach. Filter selection was based on operator preference and displayed in Table 1 . For retrieval, standard snare technique using the Cook IVC filter retrieval set (Cook Medical, Bloomington, IN) was employed for all patients.
Results
Patient demographics are displayed in Table 1 . Filters were placed in 229 patients from January 1, 2015 to December 31, 2016. Medical records were complete for data collection purposes and no patients were excluded. The mean age of patients was 67.1 years (range 16e93). Overall, the patient population was composed of 62% men (n ¼ 142) and 38% women (n ¼ 87). A cut-off date of April 1, 2017 was used to calculate time in-situ for unretrieved filters and to identify deceased patients. Of patients with in-situ filters, 71 died in the interval between filter insertion and April 1, 2017. Filters placed included the Argon Option Elite (32), Bard Denali (82), Cook Gunther-Tulip (38), and Cook Celect Platinum (77).
Indication for Filter Placement
Indications for filter placement ( Table 2) were divided into 3 categories: absolute, relative, and prophylactic indications. Absolute indications included documented VTE with one of the following: contraindication to anticoagulation (A/C) (56.8%), complication of A/C (13.1%), or failure of A/C (1.3%). Relative indications included VTE with a high risk of anticoagulation complication (2.6%), prior VTE with a contraindication to anticoagulation (0.87%), and other (2.6%). Prophylactic indications included patients with no VTE but in whom primary prophylaxis was not an option because of high risk of a bleed. This included patients with trauma and a contraindication to anticoagulation (9.2%), a surgical procedure in a patient at high risk for VTE (6.1%), and a medical condition in a patient at high risk for VTE (2.6%). Overall, 71.2% of filters were placed for absolute, 17.9% for prophylactic, and 5.7% for relative indications.
Retrieval Data
Time-to-event and retrieval data are shown in Table 3 . In total, 229 filters were placed, 113 (49.3%) retrievals were 2) , large free-floating proximal DVT (n ¼ 2), VTE with poor cardiopulmonary reserve (n ¼ 1), patients with PE for thrombectomy (n ¼ 1), non-compliance with A/C (n ¼ 1). attempted, and 101 filters (44.1%) were retrieved for an overall retrieval success rate of 89.4%. Among patients with no retrieval attempt, 71 were deceased as of April 1, 2017 at a median time to death post filter insertion of 27 days (range of 3e430, mean of 66, 95% CI [42.6e89.3]). The majority (n ¼ 94) of filters were retrieved in-house and 7 patients had successful filter retrieval at outside institutions. First attempt retrieval success rate was 85% (96/113). The median time-tofirst retrieval attempt was 48 days (range of 5e728, mean of 89, 95% CI [69.5e110]). Seventeen of the 113 first attempt retrievals (15%) were unsuccessful or not performed. Timeto-first unsuccessful retrieval attempt was 116 days (median) and 140 days (mean, 95% CI [89.6e191.2]). Five unsuccessful initial attempts required a second retrieval attempt at a success rate of 80% (4/5), and one patient had successful retrieval after a third attempt. One patient died in the interval post first retrieval attempt. Of the remaining 11 patients, filters were to remain permanently in 5 patients after a discussion between the interventional radiologist and the referring physician and thus did not have subsequent retrieval attempts. Overall, retrieval was complicated by or delayed owing to penetration of IVC wall (n ¼ 6), large thrombus burden trapped by filter (n ¼ 5), filter tilt or migration (n ¼ 3), and unclear reasons (n ¼ 3); 128 (55.9% of total) filters were never retrieved. Excluding deceased patients with in-situ filters (n ¼ 71) and unsuccessful retrievals left in-situ as permanent filters (n ¼ 5), there are 52 patients (33% of living patients) with a median filter in-situ time of 488 days (range of 91e812, mean of 479, 95% CI [420.4e537.4]).
Forty-six of these patients have never been scheduled for a retrieval attempt.
Discussion
Our study demonstrates that between January 2015 and December 2016, 229 retrievable IVCf were placed at our institution; 113 retrieval attempts were made at an overall success rate of 89.4% (101/113). Compared to a recent US based systematic literature review of 37 studies on retrievable IVCf, our results are favorable. This review reported a mean retrieval rate of 34% (range 12%e45%) and a mean time to retrieval of 72 days [4] . Before the publication of the July 2016 Health Canada Safety Alert on IVCf retrieval, 2 Canadian studies conducted at tertiary care institutions such as ours reported retrieval rates of 41.6% (n ¼ 663 filters placed) and 53.1% (n ¼ 275 filters placed) with time to retrieval of 76.4 days (mean) and 18 days (median), respectively [3, 17, 18] .
Comparing the median time to death (27 days) for patients with no retrieval attempt with the median time-to-first retrieval attempt (48 days), the 71 deceased patients with in-situ filters arguably died before their transient risk of PE subsided and therefore never became candidates for filter retrieval. In fact, in 2014 the United States Federal Drug Administration updated a 2010 Safety Communication to include a mathematical model estimating that once the transient risk of PE has passed, the riskebenefit model favors IVCf removal between 29 and 54 days postinsertion [19] . Therefore, when evaluating retrieval rates, it is important to also consider the rate for the patient population eligible for retrieval attempt. In our study, there were 158 eligible patients giving a retrieval rate of 66% by this calculation.
Similarly, however, it is important to acknowledge the subgroup of patients who are currently living with in-situ filters and have no prior retrieval attempt. We identified 52 patients (33% of living patients) with a median filter in situ time of 488 days. These are the patients who have potentially been lost to follow-up and who require an assessment to determine if the riskebenefit model favors retrieval. Through collaboration between interventional radiology and internal medicine services, these patients and their primary care physicians will be contacted to arrange follow-up at our internal medicine ambulatory clinic. A riskebenefit assessment will be made at that time to see if retrieval should be pursued.
Low retrieval rates, as highlighted by Health Canada in their July 2016 Safety Alert, has in part been attributed to the lack of a formal strategy to ensure appropriate follow-up for IVCf patients. In fact, in this safety alert, all hospitals were encouraged to identify patients with a retrievable IVCf and assess them for removal [3] . To our knowledge, most Canadian Institutions do not use a formal process to prospectively follow patients receiving IVCf.
Several studies have however investigated factors predictive of filter retrieval. Previous retrospective reviews have concluded that thrombosis clinic involvement and hematology outpatient follow-up were important predictors of IVCf retrieval [17, 18] . Another study identified that lack of outpatient hematology clinic follow-up led to significantly more patients with IVCf lost to follow-up [20] . Although identifying patients with in-situ IVCf who have been lost to follow-up is important, it is crucial to develop appropriate methods to track patients prospectively. A recent US publication describes their experience with establishing a dedicated referral-based IVCf clinic, which enters patients who are seen in this clinic for filter insertion into an electronic database with automated reminders, allowing them to be followed prospectively. They report an increase in retrieval rate from 29%e60% after the first 100 patients were enrolled [21] . Sutphin et al, in 2015, designed and implemented a quality improvement program to address low IVCf retrieval rates. They found that both retrospective mailing of letters to patients directly and prospective scheduling of a follow-up clinic visit at the time of filter placement increased retrieval rates from 8%e40% and 52% respectively. Lynch found that contacting patients directly via mail at a set interval after filter placement increased retrieval rates from 24%e59% [22] . Furthermore and of mention, one Canadian institution has implemented an IVCf management pathway as of 2011 that consists of issuing identifying wristbands to patients receiving an IVCf. These wristbands are subsequently removed only by physician order once the filter has been retrieved, a decision has been made to keep the filter permanently, or appropriate outpatient hematology follow-up has been scheduled. This prospective strategy increased successful filter retrieval rates at their institution from 53.1% e72.8% (P ¼ .001) [23] .
Therefore, most Canadian institutions inserting IVCf have the appropriate infrastructure in place to either develop a unique strategy, or adopt one that another institution has successfully trialed in order to follow patients prospectively post filter placement. Implementing these in Canadian hospitals would avoid loss of patients to follow-up, long-term complications of filters left in-situ, and the associated costs to the health care system.
Limitations of this study include the retrospective nature and short term of follow-up. It should be noted that cause of death was not identified in this study and survival data was only collected for patients with no retrieval attempt. A 27day median time to death after filter insertion in this subgroup may suggest inappropriate referral of patients for IVCf, but further studies are required.
Conclusion
A quality assurance study at our institution over a twoyear period has demonstrated favorable results for IVCf retrieval rates when compared to previous literature. However, overall retrieval rates are still suboptimal, and as many as 33% of patients may have been lost to follow-up of their in-situ IVCf. Considering the widespread reports of longterm complications and the recent safety alert issued by HC, it is evident that a unified strategy is needed to track patients after filter insertion. Various institutions, particularly in the United States, have recently implemented strategies such as using electronic databases with automated reminders, creating a designated referral based IVCf clinic, issuing patient identifying wristbands, and arranging outpatient hematology clinic follow-up. These have proven to be successful strategies that others can incorporate at their respective institutions. We, therefore, encourage all institutions offering IVCf placement to conduct an internal review similar to this study and ensure appropriate follow-up of patients. Most importantly, moving forward prospective strategies should be developed to increase retrieval rates, improve patient care by avoiding long-term complications of IVCf, and reduce associated costs to the health care system.
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